written by reader Moderna Therapeutics……a possible IPO that every biotech investor should own?

By YVR_Trader, January 4, 2017

Moderna Therapeutics is creating quite the buzz with 12 mRNA development candidates, Moderna will be standing room only at #JPM17. They will present on Jan 9th at 2:30PT.a
from IPOBOUTIQUE.com:
Prior to last year’s J.P. Morgan Healthcare Conference, Moderna Therapeutics made waves with the largest biotech private funding round ever–a $446m round in December 2014. Moderna Therapeutics, a company that focuses on using messenger RNA, or mRNA, to spur the production of human proteins within patient cells, creating what Moderna describes as an in vivo factory for targeted therapies, had a standing room only crowd at the J.P. Morgan Healthcare Conference in California as they disclosed they are transitioning to a clinical stage biotech. According to sources, the company expects to begin the clinical trials in the first quarter of this year for for different drugs that could eventually become stand-alone companies. Moderna Therapeutics disclosed that they expect to begin testing on five other mRNA treatments later this year.
With big name partnerships that include AstraZeneca (NYSE: AZN), Merck (NYSE: MRK) and Alexion Pharmaceuticals (Nasda